These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7948058)

  • 1. Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.
    Pols H; Griez E; Verburg K; van der Werf D
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):81-5. PubMed ID: 7948058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
    Goddard AW; Woods SW; Sholomskas DE; Goodman WK; Charney DS; Heninger GR
    Psychiatry Res; 1993 Aug; 48(2):119-33. PubMed ID: 8416022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 10 microg CCK-4 premedication and 35% CO2 challenge in healthy volunteers.
    Schruers K; Pols H; Overbeek T; Griez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):409-18. PubMed ID: 10836489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of panic: a review of pharmacologic provocative tests and naturalistic monitoring data.
    Shear MK
    J Clin Psychiatry; 1986 Jun; 47 Suppl():18-26. PubMed ID: 3519589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response effects of oral yohimbine in unrestrained primates.
    Rosenblum LA; Coplan JD; Friedman S; Bassoff T
    Biol Psychiatry; 1991 Apr; 29(7):647-57. PubMed ID: 1647226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.
    Klaassen T; Klumperbeek J; Deutz NE; van Praag HM; Griez E
    Psychiatry Res; 1998 Feb; 77(3):167-74. PubMed ID: 9707299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Anxiety Sensitivity and Expectancy Manipulation on Panic-Like Response to the 35% CO2 Challenge in Healthy Subjects.
    Cosci F; Bertoli G; Mansueto G; Asiaghi M; Schruers K; Nardi AE
    Neuropsychobiology; 2019; 78(4):209-217. PubMed ID: 31437853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR; Breier A
    Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychobiology of anxiety and anxiety disorders.
    Rainey JM; Nesse RM
    Psychiatr Clin North Am; 1985 Mar; 8(1):133-44. PubMed ID: 2986083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 35% carbon dioxide (CO
    Kellner M; Muhtz C; Nowack S; Leichsenring I; Wiedemann K; Yassouridis A
    J Psychiatr Res; 2018 Jan; 96():260-264. PubMed ID: 29128558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible role of locus coeruleus noradrenergic activity in anxiety-panic.
    Redmond DE
    Clin Neuropharmacol; 1986; 9 Suppl 4():40-2. PubMed ID: 3032432
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to hyperventilation in a group of patients with panic disorder.
    Gorman JM; Askanazi J; Liebowitz MR; Fyer AJ; Stein J; Kinney JM; Klein DF
    Am J Psychiatry; 1984 Jul; 141(7):857-61. PubMed ID: 6428243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
    Silverstone PH; Cowen PJ
    Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
    Gurguis GN; Uhde TW
    Psychoneuroendocrinology; 1990; 15(3):217-24. PubMed ID: 2255749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks.
    Nardi AE; Valença AM; Nascimento I; Mezzasalma MA; Zin WA
    Psychiatry Res; 2000 May; 94(2):179-84. PubMed ID: 10808043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific sensitivity of patients with panic attacks to carbon dioxide inhalation.
    Griez E; de Loof C; Pols H; Zandbergen J; Lousberg H
    Psychiatry Res; 1990 Feb; 31(2):193-9. PubMed ID: 2109330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam blockade of CO2-provoked panic in patients with panic disorder.
    Sanderson WC; Wetzler S; Asnis GM
    Am J Psychiatry; 1994 Aug; 151(8):1220-2. PubMed ID: 8037259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients.
    Schruers K; Klaassen T; Pols H; Overbeek T; Deutz NE; Griez E
    Psychiatry Res; 2000 Apr; 93(3):179-87. PubMed ID: 10760376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.